About NACC Pharmaceutical
NACC Pharmaceutical is a Healthcare company. Pharmaceutical products and services in healthcare, focusing on innovation and therapeutic solutions in India. The company has 6 employees. Its Indian entity Nacc Pharmaceutical Private Limited reported revenue of ₹64.1 Lakh. NACC Pharmaceutical offers products and services including Hypertension Drugs and Diabetes Drugs. Its focus areas include Pharmaceuticals, Drug Manufacturing, Therapeutic Solutions and Wellness.
Company details
NACC Pharmaceutical Pvt. Ltd. is identified as a leading healthcare entity with a global presence, where products for hypertension, diabetes, and neurology are offered to enhance quality of life. The companys portfolio is expanded across multiple therapeutic areas and dosage forms, with research and development efforts being directed towards addressing unmet medical needs in India. Innovation is integrated through advanced manufacturing and a strong sales team, while a culture of customer service is maintained to position it as a major player in the pharmaceutical market. Holistic expertise is utilized to aim for excellence in the industry.
- Employees 6
- SectorsHealthcare
- Email••••••••
- Legal Name Nacc Pharmaceutical Pvt. Ltd
- Date of Incorporation 19 Dec, 2019
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹64.1 Lakh
FY 2025 · -15% YoY
- Indian entity net profit₹1 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹4.8 Lakh
FY 2025 · 8% margin
- Employee Count6
Associated legal entities of NACC Pharmaceutical
NACC Pharmaceutical operates through Nacc Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nacc Pharmaceutical Private Limited CIN U24110KA2019PTC130795 | Active | 19 Dec 2019 | Bangalore, Karnataka | ₹0.6 Cr | 6 | 2 | View details |
Products & Services of NACC Pharmaceutical
NACC Pharmaceutical offers a comprehensive portfolio of products and services, including Hypertension Drugs and Diabetes Drugs.
Drugs for hypertension are developed and distributed across various dosage forms.
Medications for diabetes are provided as part of the therapeutic portfolio.
Board of directors of Nacc Pharmaceutical Private Limited (NACC Pharmaceutical)
Nacc Pharmaceutical Private Limited is the primary company behind NACC Pharmaceutical. The board of Nacc Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Venkataramanappa Adinarayana Sravan Kumar, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkataramanappa Adinarayana Sravan Kumar DIN 08643149 | Director | 19 Dec 2019 | 6 yrs 10 mo | Nacc Pharmaceutical Private Limited |
| Chowdappa Geetha DIN 10903543 | Additional Director | 11 Jan 2025 | 1 yr 9 mo | Nacc Pharmaceutical Private Limited |
Financials of NACC Pharmaceutical
Figures of Nacc Pharmaceutical Private Limited, the primary company behind NACC Pharmaceutical, for FY 2025. Revenue was ₹64.1 Lakh (-15% year on year). Net profit was ₹1 Lakh (2% margin). EBITDA was ₹4.8 Lakh (8% margin). Revenue has grown at a compounded annual rate of +7% over three years.
- ₹64.1 LakhRevenue · FY 2025 · -15% YoY
- ₹1 LakhNet profit · 2% margin
- ₹4.8 LakhEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- 6Employees (provident fund records)
- +7%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nacc Pharmaceutical Private Limited are on its company page.
Detailed financial statements for NACC Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NACC Pharmaceutical
NACC Pharmaceutical has 6 employees.
The primary company behind NACC Pharmaceutical, Nacc Pharmaceutical Private Limited, reported revenue of ₹64.1 Lakh for FY 2025, down 15% year on year.
NACC Pharmaceutical Pvt. Ltd. is identified as a leading healthcare entity with a global presence, where products for hypertension, diabetes, and neurology are offered to enhance quality of life. The companys portfolio is expanded across multiple therapeutic areas and dosage forms, with research and development efforts being directed towards addressing unmet medical needs in India. Innovation is integrated through advanced manufacturing and a strong sales team, while a culture of customer service is maintained to position it as a major player in the pharmaceutical market. Holistic expertise is utilized to aim for excellence in the industry.
NACC Pharmaceutical offers Hypertension Drugs and Diabetes Drugs.
NACC Pharmaceutical operates through Nacc Pharmaceutical Private Limited.
The legal entities of NACC Pharmaceutical currently have 2 directors, including Venkataramanappa Adinarayana Sravan Kumar, Chowdappa Geetha.